세계의 당뇨병성 망막증 시장 보고서(2025년)

Diabetic retinopathy is a complication of diabetes that impacts the retina, the light-sensitive tissue at the back of the eye. It occurs due to damage to the blood vessels caused by prolonged high blood sugar levels. If not properly managed, this condition can lead to vision loss and even blindness, underscoring the importance of regular eye examinations for early detection and treatment.

The primary types of diabetic retinopathy include proliferative diabetic retinopathy and non-proliferative diabetic retinopathy. Proliferative diabetic retinopathy represents the advanced stage characterized by the emergence of abnormal new blood vessels on the surface of the retina. Various treatment modalities, such as anti-VEGF drugs, intraocular steroid injections, laser photocoagulation, and vitreoretinal surgery, are employed in settings such as hospitals, ambulatory surgical centers, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The diabetic retinopathy market research report is one of a series of new reports from The Business Research Company that provides diabetic retinopathy market statistics, including diabetic retinopathy industry global market size, regional shares, competitors with a diabetic retinopathy market share, detailed diabetic retinopathy market segments, market trends and opportunities, and any further data you may need to thrive in the diabetic retinopathy industry. This diabetic retinopathy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The diabetic retinopathy market size has grown strongly in recent years. It will grow from $8.61 billion in 2024 to $9.26 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to aging population, increasing prevalence of diabetes, growing awareness about diabetic retinopathy, improved healthcare infrastructure, rising healthcare expenditure.

The diabetic retinopathy market size is expected to see strong growth in the next few years. It will grow to $12.5 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to personalized medicine approaches, expansion of telemedicine services, development of novel therapeutic interventions, adoption of point-of-care testing, remote patient monitoring. Major trends in the forecast period include precision medicine in diabetic retinopathy treatment, increased focus on early detection and prevention, teleophthalmology services growth, rise in gene therapy research, continuous advancements in retinal imaging technology.

The forecast of 7.8% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. eye clinics by driving up the cost of fundus cameras and Artificial intelligence(AI)-based screening software sourced from Japan and Sweden, exacerbating preventive care expenses for high-risk populations. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of diabetes is expected to drive the growth of the diabetic retinopathy market in the future. Diabetes is a chronic metabolic disease characterized by high blood glucose levels. This rise in diabetes prevalence is largely influenced by factors such as overweight, obesity, genetics, and physical inactivity. High blood sugar levels can damage the retina, the part of the eye responsible for detecting light and sending signals to the brain through a nerve at the back of the eye. For example, a report from the Office for Health Improvement and Disparities, a UK government department, indicated that from March 2022 to March 2023, the percentage of individuals with type 1 diabetes receiving all eight recommended care processes increased by 22%, while type 2 diabetes saw a 21% rise. Additionally, the proportion of people achieving target HbA1c levels reached 37.9%, the highest recorded by the National Diabetes Audit. Thus, the growing prevalence of diabetes is significantly contributing to the expansion of the diabetic retinopathy market.

The increasing proportion of aging individuals is anticipated to drive the growth of the diabetic retinopathy market in the future. Aging individuals refer to those who are progressing in age and experiencing the effects of aging. This process is associated with a heightened susceptibility to chronic conditions, such as diabetes, which raises the risk and enlarges the population vulnerable to diabetic retinopathy. For instance, a report from the World Health Organization, a Switzerland-based agency, indicated that by 2050, 80% of older individuals are expected to live in low- and middle-income countries. By 2030, one in six people worldwide will be aged 60 years or older, significantly increasing the proportion of the population in this age group. Furthermore, the global population of individuals aged 60 and older is projected to double by 2050, reaching 2.1 billion. Therefore, the growing proportion of aging individuals is contributing to the expansion of the diabetic retinopathy market.

Technological advancements represent a prominent trend gaining traction in the diabetic retinopathy market. Major companies within this market are embracing innovative technologies to maintain their competitive standing. For instance, in July 2022, Baxter International Inc., a US-based healthcare company, introduced the Welch Allyn RetinaVue 100 Imager PRO in South Korea. These cutting-edge technologies aim to facilitate the detection of diabetic retinopathy in primary care settings, streamlining the process for annual diabetic retinal exams (DREs) during routine primary care visits and enhancing patient compliance.

Companies operating in the diabetic retinopathy market are strategically entering partnerships to enhance their market profitability. Collaborations in the context of diabetic retinopathy involve coordinated efforts among diverse stakeholders, including healthcare providers, researchers, pharmaceutical companies, and advocacy groups, to address challenges associated with diabetic retinopathy. For example, in October 2023, AEYE Health, a US-based provider of AI-based diagnostics for retinal imaging, joined forces with Topcon Screen, a Japan-based diabetic screening platform. Their collaboration aims to offer point-of-care screening for diabetic retinopathy using artificial intelligence, ensuring swift and precise results. This approach enables primary care clinicians to conduct diabetic retinopathy screenings directly in their clinics, reducing non-compliance risks and addressing care gaps associated with diabetic retinopathy screening through immediate and accurate assessments at the point of care.

In January 2022, Meteda, a US-based healthcare technology company, completed the acquisition of Retmarker SA for an undisclosed amount. Through this strategic move, Meteda seeks to broaden its access to periodic screening for diabetic retinopathy, utilize AI to address various diabetes-related issues, and strengthen its position in the EMEA region. Retmarker SA, based in Portugal, is an AI technology company specializing in ophthalmology, particularly focusing on retinal conditions such as diabetic retinopathy.

Major companies operating in the diabetic retinopathy market include Pfizer Inc., F-Hoffmann-La Roche Ltd., Abbvie Inc., Bayer AG, Novartis AG, Ellex Medical Lasers Ltd., Abbott Laboratories Inc., Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Icon Bioscience Inc., Allergan plc., Genentech Inc., Aurobindo Pharma, Santen Pharmaceutical Co. Ltd., Carl Zeiss Meditec AG, Valeant Pharmaceuticals International Inc., Lumenis Ltd., Optos Plc., Quantel Medical SAS, NIDEK Co. Ltd., IRIDEX Corporation, Alimera Science Inc., Kowa Company Ltd., Ocular Therapeutix Inc., Aerpio Pharmaceuticals Inc., Kodiak Sciences Inc., Oxurion NV, Graybug Vision Inc., Ampio Pharmaceuticals Inc.

North America was the largest region in the diabetic retinopathy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetic retinopathy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the diabetic retinopathy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The diabetic retinopathy market includes revenues earned by entities by providing ophthalmologic examination, eye management and retinal imaging and monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Diabetic Retinopathy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on diabetic retinopathy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for diabetic retinopathy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The diabetic retinopathy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Proliferative Diabetic Retinopathy; Non-Proliferative Diabetic Retinopathy
• 2) By Treatment: Anti-VEGF Drugs; Intraocular Steroid Injection; Laser Photocoagulation; Vitreoretinal Surgery
• 3) By End-User: Hospitals; Ambulatory Surgical Centers; Other End Users
• Subsegments:
• 1) By Proliferative Diabetic Retinopathy (PDR): Neovascularization; Vitreous Hemorrhage; Tractional Retinal Detachment
• 2) By Non-Proliferative Diabetic Retinopathy (NPDR): Mild NPDR; Moderate NPDR; Severe NPDR
• Companies Mentioned: Pfizer Inc.; F-Hoffmann-La Roche Ltd.; Abbvie Inc.; Bayer AG; Novartis AG; Ellex Medical Lasers Ltd.; Abbott Laboratories Inc.; Regeneron Pharmaceuticals Inc.; Bausch Health Companies Inc.; Icon Bioscience Inc.; Allergan plc.; Genentech Inc.; Aurobindo Pharma; Santen Pharmaceutical Co. Ltd.; Carl Zeiss Meditec AG; Valeant Pharmaceuticals International Inc.; Lumenis Ltd.; Optos Plc.; Quantel Medical SAS; NIDEK Co. Ltd.; IRIDEX Corporation; Alimera Science Inc.; Kowa Company Ltd.; Ocular Therapeutix Inc.; Aerpio Pharmaceuticals Inc.; Kodiak Sciences Inc.; Oxurion NV; Graybug Vision Inc.; Ampio Pharmaceuticals Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Diabetic Retinopathy Market Characteristics

3. Diabetic Retinopathy Market Trends And Strategies

4. Diabetic Retinopathy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Diabetic Retinopathy Growth Analysis And Strategic Analysis Framework

• 5.1. Global Diabetic Retinopathy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Diabetic Retinopathy Market Growth Rate Analysis
• 5.4. Global Diabetic Retinopathy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Diabetic Retinopathy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Diabetic Retinopathy Total Addressable Market (TAM)

6. Diabetic Retinopathy Market Segmentation

• 6.1. Global Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Proliferative Diabetic Retinopathy
• Non-Proliferative Diabetic Retinopathy
• 6.2. Global Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Anti-VEGF Drugs
• Intraocular Steroid Injection
• Laser Photocoagulation
• Vitreoretinal Surgery
• 6.3. Global Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Ambulatory Surgical Centers
• Other End Users
• 6.4. Global Diabetic Retinopathy Market, Sub-Segmentation Of Proliferative Diabetic Retinopathy (PDR), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Neovascularization
• Vitreous Hemorrhage
• Tractional Retinal Detachment
• 6.5. Global Diabetic Retinopathy Market, Sub-Segmentation Of Non-Proliferative Diabetic Retinopathy (NPDR), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mild NPDR
• Moderate NPDR
• Severe NPDR

7. Diabetic Retinopathy Market Regional And Country Analysis

• 7.1. Global Diabetic Retinopathy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Diabetic Retinopathy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Diabetic Retinopathy Market

• 8.1. Asia-Pacific Diabetic Retinopathy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Diabetic Retinopathy Market

• 9.1. China Diabetic Retinopathy Market Overview
• 9.2. China Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Diabetic Retinopathy Market

• 10.1. India Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Diabetic Retinopathy Market

• 11.1. Japan Diabetic Retinopathy Market Overview
• 11.2. Japan Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Diabetic Retinopathy Market

• 12.1. Australia Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Diabetic Retinopathy Market

• 13.1. Indonesia Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Diabetic Retinopathy Market

• 14.1. South Korea Diabetic Retinopathy Market Overview
• 14.2. South Korea Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Diabetic Retinopathy Market

• 15.1. Western Europe Diabetic Retinopathy Market Overview
• 15.2. Western Europe Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Diabetic Retinopathy Market

• 16.1. UK Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Diabetic Retinopathy Market

• 17.1. Germany Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Diabetic Retinopathy Market

• 18.1. France Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Diabetic Retinopathy Market

• 19.1. Italy Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Diabetic Retinopathy Market

• 20.1. Spain Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Diabetic Retinopathy Market

• 21.1. Eastern Europe Diabetic Retinopathy Market Overview
• 21.2. Eastern Europe Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Diabetic Retinopathy Market

• 22.1. Russia Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Diabetic Retinopathy Market

• 23.1. North America Diabetic Retinopathy Market Overview
• 23.2. North America Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Diabetic Retinopathy Market

• 24.1. USA Diabetic Retinopathy Market Overview
• 24.2. USA Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Diabetic Retinopathy Market

• 25.1. Canada Diabetic Retinopathy Market Overview
• 25.2. Canada Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Diabetic Retinopathy Market

• 26.1. South America Diabetic Retinopathy Market Overview
• 26.2. South America Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Diabetic Retinopathy Market

• 27.1. Brazil Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Diabetic Retinopathy Market

• 28.1. Middle East Diabetic Retinopathy Market Overview
• 28.2. Middle East Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Diabetic Retinopathy Market

• 29.1. Africa Diabetic Retinopathy Market Overview
• 29.2. Africa Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Diabetic Retinopathy Market Competitive Landscape And Company Profiles

• 30.1. Diabetic Retinopathy Market Competitive Landscape
• 30.2. Diabetic Retinopathy Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F-Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbvie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Diabetic Retinopathy Market Other Major And Innovative Companies

• 31.1. Ellex Medical Lasers Ltd.
• 31.2. Abbott Laboratories Inc.
• 31.3. Regeneron Pharmaceuticals Inc.
• 31.4. Bausch Health Companies Inc.
• 31.5. Icon Bioscience Inc.
• 31.6. Allergan plc.
• 31.7. Genentech Inc.
• 31.8. Aurobindo Pharma
• 31.9. Santen Pharmaceutical Co. Ltd.
• 31.10. Carl Zeiss Meditec AG
• 31.11. Valeant Pharmaceuticals International Inc.
• 31.12. Lumenis Ltd.
• 31.13. Optos Plc.
• 31.14. Quantel Medical SAS
• 31.15. NIDEK Co. Ltd.

32. Global Diabetic Retinopathy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Diabetic Retinopathy Market

34. Recent Developments In The Diabetic Retinopathy Market

35. Diabetic Retinopathy Market High Potential Countries, Segments and Strategies

• 35.1 Diabetic Retinopathy Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Diabetic Retinopathy Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Diabetic Retinopathy Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer